Tag her2 [79 articles] Export

Recent papers classified by the tag her2.

	Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab [My Copy] Nature, Vol. 421, No. 6924. (13 February 2003), pp. 756-760. by Hyun-Soo Cho, Karen Mason, Kasra X. Ramyar, et al.Ann M. Stanley, Sandra B. Gabelli, Dan W. Denney, Daniel J. Leahy posted to trastuzumab her2 egfr crystal_structure cho cancer by mat956 on 2009-11-29 15:50:04 as along with 1 person beapen
	Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. [My Copy] Nature clinical practice. Oncology, Vol. 3, No. 5. (01 May 2006), pp. 269-280. by Rita Nahta, Dihua Yu, Mien-Chie C. Hung, Gabriel N. Hortobagyi, Francisco J. Esteva posted to trastuzumab signaling_pathway review nahta multidrug_resistance her2 cancer breast_cancer by mat956 on 2009-11-28 20:54:31 as along with 2 people jfr pjasper
	HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. [My Copy] Oncogene, Vol. 22, No. 21. (22 May 2003), pp. 3205-3212. by Christiane Knuefermann, Yang Lu, Bolin Liu, et al.Weidong Jin, Ke Liang, Ling Wu, Mathias Schmidt, Gordon B. Mills, John Mendelsohn, Zhen Fan posted to signaling_pathway pi3k-akt multidrug_resistance knuefermann her2 cancer breast_cancer by mat956 on 2009-11-28 20:29:05 as
	The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. [My Copy] Molecular cell, Vol. 11, No. 2. (February 2003), pp. 495-505. by Thomas P. Garrett, Neil M. McKern, Meizhen Lou, et al.Thomas C. Elleman, Timothy E. Adams, George O. Lovrecz, Michael Kofler, Robert N. Jorissen, Edouard C. Nice, Antony W. Burgess, Colin W. Ward posted to her2 garrett egfr crystal_structure by mat956 on 2009-11-28 19:57:05 as along with 1 person beapen
	ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. [My Copy] Nature, Vol. 461, No. 7261. (10 September 2009), pp. 287-291. by Diego Alvarado, Daryl E. Klein, Mark A. Lemmon posted to her2 egfr crystal_structure cancer alvarado by mat956 on 2009-11-28 19:44:24 as along with 1 person renatomilani
	Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas. [My Copy] Tumori, Vol. 91, No. 6. (c 2005), pp. 513-521. by Seock-Ah A. Im, Kyung Eun, Eunmi Nam, et al. Do Yeun, Joo-Ho H. Lee, Ho-Seong S. Han, Ju-Young Y. Seoh, Hae-Young Y. Park, Min-Sun S. Cho, Woon Sup, Soon Nam posted to pten im her2 gastric_cancer cancer by mat956 on 2009-11-28 19:12:32 as
	HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 19, No. 9. (1 September 2008), pp. 1523-1529. by C. Gravalos, A. Jimeno posted to review prognostic_factor her2 gravalos gastric_cancer cancer by mat956 on 2009-11-28 19:06:06 as
	Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis [My Copy] Vol. 6, No. 5. (1 November 2004), pp. 459-469. by Yan M. Li, Yong Pan, Yongkun Wei, et al.Xiaoyun Cheng, Binhua P. Zhou, Ming Tan, Xiaoyan Zhou, Weiya Xia, Gabriel N. Hortobagyi, Dihua Yu, Mien-Chie Hung posted to signaling_pathway metastasis li her2 cxcr4 cancer breast_cancer by mat956 on 2009-11-28 13:09:58 as
	Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. [My Copy] British journal of cancer, Vol. 95, No. 11. (4 December 2006), pp. 1504-1513. by H. Yokoyama, Y. Ikehara, Y. Kodera, et al.S. Ikehara, Y. Yatabe, Y. Mochizuki, M. Koike, M. Fujiwara, A. Nakao, M. Tatematsu, H. Nakanishi posted to yokoyama trastuzumab tki signaling_pathway pten pi3k-akt multidrug_resistance metastasis mapk her2 gefitinib gastric_cancer egfr cancer apoptosis by mat956 on 2009-11-28 12:27:01 as along with 2 people pjasper klu
	Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 46. (17 November 2009), pp. 19503-19508. by Anthony C. Faber, Danan Li, YoungChul Song, et al.Mei-Chih Liang, Beow Y. Yeap, Roderick T. Bronson, Eugene Lifshits, Zhao Chen, Sauveur-Michel Maira, Carlos GarcÃa-EcheverrÃa, Kwok-Kin Wong, Jeffrey A. Engelman posted to tki signaling_pathway pi3k-akt her2 gefitinib faber egfr cancer apoptosis by mat956 on 2009-11-28 12:05:59 as along with 1 person paulschlesinger
	HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 1. (2 January 2008), pp. 14-20. by Alessandra Gennari, Maria Pia P. Sormani, Paolo Pronzato, et al.Matteo Puntoni, Mariantonietta Colozza, Ulrich Pfeffer, Paolo Bruzzi posted to randomized_controlled_trial pooling meta_anlaysis her2 chemotherapy breast anthracycline by misonneh on 2009-11-27 10:58:52 as
	Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. [My Copy] British journal of cancer, Vol. 101, No. 1. (7 July 2009), pp. 149-159. by P. de Graeff, A. P. Crijns, S. de Jong, et al.M. Boezen, W. J. Post, E. G. de Vries, A. G. van der Zee, G. H. de Bock posted to time_to_event ovarian meta_analysis her2 by misonneh on 2009-11-27 08:59:54 as
	Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 21, No. 21. (1 November 2003), pp. 3940-3947. by Wen-Kai K. Weng, Ronald Levy posted to trastuzumab pharmacogenetics lymphoma her2 fcr3a fcr2a cancer by songpku on 2009-11-24 18:34:18 as
	FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 24. (20 August 2007), pp. 3712-3718. by Wu Zhang, Michael Gordon, Anne M. Schultheis, et al.Dong Yun Y. Yang, Fumio Nagashima, Mizutomo Azuma, Heung-Moon M. Chang, Eva Borucka, Georg Lurje, Andy E. Sherrod, Syma Iqbal, Susan Groshen, Heinz-Josef J. Lenz posted to trastuzumab pharmacogenetics her2 fcgr3a fcgr2a colorectal cancer by songpku on 2009-11-24 18:30:34 as
	Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 22. (15 November 2009), pp. 7003-7011. by Paul Roepman, Hugo M. Horlings, Oscar Krijgsman, et al.Marleen Kok, Jolien M. Bueno-de-Mesquita, Richard Bender, Sabine C. Linn, Annuska M. Glas, Marc J. van de Vijver posted to pr mrnaarray her2 gene_signature er classifier by tonamswish on 2009-11-23 22:35:02 as along with 1 person csimmons
	Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. [My Copy] BMC cancer, Vol. 9 (29 May 2009), 165. by Gulisa Turashvili, Samuel Leung, Dmitry Turbin, et al.Kelli Montgomery, Blake Gilks, Rob West, Melinda Carrier, David Huntsman, Samuel Aparicio posted to immunohistochemistry her2 fish concordance breast_cancer by jfr on 2009-11-19 13:36:57 as along with 1 person gturashvili
	Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer. [My Copy] Breast cancer research and treatment (20 May 2009) by Thomas Karn, Dirk Metzler, Eugen Ruckhäberle, et al.Lars Hanker, Regine Gätje, Christine Solbach, Andre Ahr, Marcus Schmidt, Uwe Holtrich, Manfred Kaufmann, Achim Rody posted to subtypes proliferation pr meta-analysis her2 er breast_cancer by jfr on 2009-11-18 13:14:00 as
	Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 101, No. 10. (20 May 2009), pp. 736-750. by Maggie C. Cheang, Stephen K. Chia, David Voduc, et al.Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen posted to subtypes rt-pcr proliferation pr luminal_subtype immunohistochemistry her2 er breast_cancer by jfr on 2009-11-15 14:43:06 as along with 1 person zufar
	MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. [My Copy] Breast cancer research : BCR, Vol. 11, No. 3. (11 May 2009), R27. by Aoife J. Lowery, Nicola Miller, Amanda Devaney, et al.Roisin E. McNeill, Pamela A. Davoren, Christophe Lemetre, Vladimir Benes, Sabine Schmidt, Jonathon Blake, Graham Ball, Michael J. Kerin posted to pr mirna her2 er breast_cancer by jfr to the group microRNA on 2009-11-13 11:46:37 as along with 2 people tonamswish giovenko
	Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 5. (1 March 2008), pp. 1368-1376. by Maggie C. Cheang, David Voduc, Chris Bajdik, et al.Samuel Leung, Steven McKinney, Stephen K. Chia, Charles M. Perou, Torsten O. Nielsen posted to triple-negative subtypes hr her2 breast biomarker basal-like by misonneh on 2009-11-10 05:42:06 as along with 4 people songpku NaliniChilkov Zephyrus jfr
	Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. [My Copy] British journal of cancer, Vol. 101, No. 8. (20 October 2009), pp. 1253-1260. by M. Hauglid Flågeng, Haugan L. Moi, J. M. Dixon, et al.J. Geisler, E. A. Lien, W. R. Miller, P. E. Lønning, G. Mellgren posted to response prediction nuclear_receptor neoadjuvant kim_ her2 expression breast aromatase_inhibitor by misonneh on 2009-11-03 06:03:37 as
	CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. [My Copy] Breast cancer research : BCR, Vol. 9, No. 6. (17 December 2007), R87. by Francisco J. Esteva, Jing Wang, Feng Lin, et al.Jaime A. Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U. Buzdar, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai posted to response prediction neoadjuvant immunity her2 breast biomarker by misonneh on 2009-10-19 08:49:42 as
	Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study [My Copy] J Clin Oncol (28 September 2009), JCO.2008.20.6847. by Bella Kaufman, John R. Mackey, Michael R. Clemens, et al.Poonamalle P. Bapsy, Ashok Vaid, Andrew Wardley, Sergei Tjulandin, Michaela Jahn, Michaela Lehle, Andrea Feyereislova, Cedric Revil, Alison Jones posted to met_brca her2 by aeisen on 2009-09-29 17:49:16 as
	Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004. [My Copy] The breast journal (17 September 2009) by Carol A. Parise, Katrina R. Bauer, Monica M. Brown, Vincent Caggiano posted to progesterone-receptor pr her2 estrogen-receptor cancer breast by Zephyrus on 2009-09-28 05:45:15 as
	Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family [My Copy] Nat Rev Cancer, Vol. 9, No. 9. (September 2009), pp. 615-630. by Jianming Xu, Ray-Chang Wu, Bert W. O'Malley posted to steroid src review moa her2 breast by misonneh on 2009-08-26 11:38:59 as along with 2 people ondrej thegoose
	Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. [My Copy] Cancer research, Vol. 69, No. 16. (15 August 2009), pp. 6713-6720. by Dana Faratian, Alexey Goltsov, Galina Lebedeva, et al.Anatoly Sorokin, Stuart Moodie, Peter Mullen, Charlene Kay, In Hwa H. Um, Simon Langdon, Igor Goryanin, David J. Harrison posted to trastuzumab systems_biology pten personalized_medicine kinetic_modeling her2 by frohike on 2009-08-13 08:18:05 as along with 4 people karthikraman schwartzjmc bertelsen ericrpaquet
	Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines. [My Copy] Molecular cancer therapeutics, Vol. 6, No. 10. (October 2007), pp. 2664-2674. by David R. Emlet, Kathryn A. Brown, Deborah L. Kociban, et al.Agnese A. Pollice, Charles A. Smith, Ben Brian B. Ong, Stanley E. Shackney posted to cancer her2 by DiegoAlonzo on 2009-08-06 04:28:03 as
	Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [My Copy] Nat Rev Cancer, Vol. 9, No. 7. (18 July 2009), pp. 463-475. by Jose Baselga, Sandra M. Swain posted to chemotherapy her2 resistance review by misonneh on 2009-07-27 08:56:03 as along with 2 people sschurer renatomilani
	Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. [My Copy] Breast cancer research and treatment (18 February 2009) by Christopher L. Tebbit, Jun Zhai, Brian R. Untch, et al.Matthew J. Ellis, Holly K. Dressman, Rex C. Bentley, Jay A. Baker, Paul K. Marcom, Joseph R. Nevins, Jeffrey R. Marks, John A. Olson posted to breast_cancer estrogen gene_expression her2 by jfr on 2009-07-03 14:21:22 as
	The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study. [My Copy] The American journal of surgical pathology, Vol. 29, No. 9. (September 2005), pp. 1221-1227. by E. Downs-Kelly, B. J. Yoder, M. Stoler, et al.R. R. Tubbs, M. Skacel, T. Grogan, P. Roche, D. G. Hicks posted to her2 measurement thelist superlist by Zephyrus on 2009-06-23 08:55:42 as
	Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. [My Copy] Human pathology, Vol. 36, No. 3. (March 2005), pp. 250-261. by D. G. Hicks, R. R. Tubbs posted to her2 measurement thelist superlist by Zephyrus on 2009-06-23 08:54:59 as
	Risk of breast cancer according to the status of HER-2/neu oncogene amplification. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 9, No. 1. (January 2000), pp. 65-71. by W. Y. Huang, B. Newman, R. C. Millikan, et al.K. Conway, B. S. Hulka, M. J. Schell, E. T. Liu posted to cancer her2 breast thelist superlist by Zephyrus on 2009-06-18 00:40:40 as
	The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer. [My Copy] British journal of cancer, Vol. 100, No. 7. (7 April 2009), pp. 1061-1067. by C. Horlock, B. Stott, P. J. Dyson, et al.M. Morishita, R. C. Coombes, P. Savage, J. Stebbing posted to cancer her2 relationship th17 treg breast thelist superlist by Zephyrus on 2009-06-09 13:36:57 as along with 1 person davide_caldo
	Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women [My Copy] Cancer, Vol. 97, No. 6. (2003), pp. 1393-1403. by Neesha A. Rodrigues, Deborah Dillon, Darryl Carter, Nicole Parisot, Bruce G. Haffty posted to cancer her2 breast thelist by Zephyrus on 2009-06-06 11:37:02 as
	Trastuzumab--mechanism of action and use in clinical practice. [My Copy] N Engl J Med, Vol. 357, No. 1. (5 July 2007), pp. 39-51. by C. A. Hudis posted to cancer her2 breast thelist superlist by Zephyrus on 2009-06-05 13:03:59 as along with 2 people guhjy jfr
	Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. [My Copy] Nat Cell Biol, Vol. 3, No. 3. (March 2001), pp. 245-252. by B. P. Zhou, Y. Liao, W. Xia, B. Spohn, M. H. Lee, M. C. Hung posted to akt her2 p21 proliferation by bloomekj on 2009-05-30 05:27:17 as along with 1 person guhjy
	Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. [My Copy] Human pathology, Vol. 37, No. 9. (September 2006), pp. 1217-1226. by M. J. Kim, J. Y. Ro, S. H. Ahn, H. H. Kim, S. B. Kim, G. Gong posted to aggressiveness aggressiveness-prediction basal cancer check her2 korea prognosis breast thelist by Zephyrus on 2009-05-18 23:17:56 as
	Are we HER-ting for innovation in neoadjuvant breast cancer trial design? [My Copy] Breast Cancer Research, Vol. 11 (16 January 2009), 201. by Natasa, Martine Piccart posted to cancer clinical her2 neoadjuvant trial methods breast thelist by Zephyrus on 2009-05-06 02:19:25 as
	EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. [My Copy] Breast cancer research and treatment, Vol. 79, No. 2. (May 2003), pp. 187-198. by A. Lebeau, A. Unholzer, G. Amann, et al.M. Kronawitter, I. Bauerfeind, A. Sendelhofert, A. Iff, U. Löhrs posted to cancer cyclin dcis egfr her2 p53 breast thelist by Zephyrus on 2009-05-04 19:16:00 as
	Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors [My Copy] Breast Cancer Research, Vol. 10 (16 May 2008), R46. by Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, et al.Sandy L. Nguyen, Anh-Thu Vu, Armando E. Giuliano, Dave S. B. Hoon posted to breast epigenetics esr1 her2 methylation prognosis by misonneh on 2009-04-30 10:38:22 as
	Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines [My Copy] Laboratory Investigation, Vol. aop, No. current. by Edurne Arriola, Caterina Marchio, David S. P. Tan, et al.Suzanne C. Drury, Maryou B. Lambros, Rachael Natrajan, Socorro M. Rodriguez-Pinilla, Alan Mackay, Narinder Tamber, Kerry Fenwick, Chris Jones, Mitch Dowsett, Alan Ashworth, Jorge S. Reis-Filho posted to 17q12 aggressiveness cancer gene-expression her2 molecular top2a breast thelist by Zephyrus on 2009-04-27 13:43:21 as
	The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker. [My Copy] European journal of cancer (Oxford, England : 1990), Vol. 37 Suppl 1 (January 2001), pp. 3-10. by T Cooke, J Reeves, A Lannigan, P Stanton posted to aggressiveness cancer her2 breast thelist superlist by Zephyrus on 2009-04-09 23:16:49 as
	HER2 testing in breast cancer: NCCN Task Force report and recommendations. [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 4 Suppl 3 (July 2006) by R. W. Carlson, S. J. Moench, M. E. Hammond, et al.E. A. Perez, H. J. Burstein, D. C. Allred, C. L. Vogel, L. J. Goldstein, G. Somlo, W. J. Gradishar, C. A. Hudis, M. Jahanzeb, A. Stark, A. C. Wolff, M. F. Press, E. P. Winer, S. Paik, B. M. Ljung, posted to background dod her2 list thelist superlist by Zephyrus on 2009-03-07 20:19:09 as
	Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer [My Copy] J Clin Pathol, Vol. 58, No. 6. (1 June 2005), pp. 611-616. by H. J. Huang, P. Neven, M. Drijkoningen, et al.R. Paridaens, H. Wildiers, E. Van Limbergen, P. Berteloot, F. Amant, I. Vergote, M. R. Christiaens posted to cancer characteristics her2 methods outcome stage tumour breast thelist by Zephyrus on 2009-02-17 00:15:14 as
	CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, No. 9. (1 May 2007), pp. 2714-2721. by S. A. Perez, M. V. Karamouzis, D. V. Skarlos, et al.A. Ardavanis, N. N. Sotiriadou, E. G. Iliopoulou, M. L. Salagianni, G. Orphanos, C. N. Baxevanis, G. Rigatos, M. Papamichail posted to background cancer her2 immunology justification treg-bc treg-cancer breast thelist superlist by Zephyrus on 2009-02-11 19:52:07 as
	Basal vs. luminal a breast cancer subtypes: a matched case-control study using estrogen receptor, progesterone receptor, and HER-2 as surrogate markers [My Copy] Medical Oncology (26 November 2008) by Ezzeldin Ibrahim, Aboelkhair M. Al-Gahmi, Ahmed A. Zeenelin, et al.Jamal M. Zekri, Tawfik R. Elkhodary, Hussein E. Gaballa, Ehab E. Fawzy, Mohamed E. El sayed, Mohamed S. Alzahrani posted to basal cancer disease-free estrogen-receptor grade her2 luminal molecular-histology progesterone-receptor subtypes survival breast thelist by Zephyrus on 2009-02-02 18:24:02 as
	Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers [My Copy] J Clin Oncol, Vol. 26, No. 35. (10 December 2008), pp. 5697-5704. by Stephen Chia, Brian Norris, Caroline Speers, et al.Maggie Cheang, Blake Gilks, Allen M. Gown, David Huntsman, Ivo A. Olivotto, Torsten O. Nielsen, Karen Gelmon posted to breast cancer her2 microarray overexpression tissue by songpku to the group Roswell Cancer Crosstalk on 2009-01-16 19:59:18 as along with 1 person and 1 group lrust Breast Cancer Reading Club
	Her-2/ neu -induced “Cytokine Signature” in Breast Cancer [My Copy] Hormonal Carcinogenesis V (2008), pp. 311-319. by Alejandro Vazquez-Martin, Ramon Colomer, Javier A. Menendez posted to cancer cytokine her2 signature breast thelist by Zephyrus on 2008-12-15 08:17:47 as
	ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells [My Copy] Clinical and Translational Science, Vol. 1, No. 2. (2008), pp. 107-115. by Jaime Lindsay, Xuanmao Jiao, Toshiyuki Sakamaki, et al.Mathew C. Casimiro, Lawrence A. Shirley, Thai H. Tran, Xiaoming Ju, Manran Liu, Zhiping Li, Chenguang Wang, Sanjay Katiyar, Mahadev Rao, Kathleen G. Allen, Robert I. Glazer, Changhui Ge, Pamela Stanley, Michael P. Lisanti, Hallgeir Rui, Richard G. Pestell posted to breast cancer her2 notch signalling therapy by Zephyrus to the group Breast Cancer Reading Club on 2008-12-07 17:54:43 as
	Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women [My Copy] Cancer Epidemiol Biomarkers Prev, Vol. 17, No. 8. (1 August 2008), pp. 2078-2086. by Amanda I. Phipps, Kathleen E. Malone, Peggy L. Porter, Janet R. Daling, Christopher I. Li posted to aggressiveness aggressiveness-prediction cancer her2 luminal postmenopausal size triple-negative breast thelist by Zephyrus on 2008-11-29 09:51:50 as

Note: You may cite this page as: http://www.citeulike.org/tag/her2

Result page: 1 2 Next

breast	68
cancer	63
thelist	27
egfr	16
herceptin	15
review	10
breast_cancer	9
estrogen	9
resistance	9
superlist	9
therapy	9
receptor	8
tki	8
prognosis	7
pr	6
trastuzumab	6
amplification	5
er	5
signaling_pathway	5
africa	4
aggressiveness	4
akt	4
expression	4
gefitinib	4
hormone	4
igf-1r	4
lapatinib	4
metastasis	4
microarray	4
polysomy	4
prediction	4
pten	4
sub-sahara	4
subtypes	4
tissue	4
apoptosis	3
biomarker	3
crystal_structure	3
ecd	3
gastric_cancer	3
immunohistochemistry	3
immunology	3
luminal	3
multidrug_resistance	3
neoadjuvant	3
overexpression	3
pi3k-akt	3
proliferation	3
reference	3
survival	3
transcription_factor	3
aggressiveness-prediction	2
antibody	2
background	2
basal	2
chemotherapy	2
crosstalk	2
dcis	2
dendrimer	2
efficacy	2
estrogen-receptor	2
esx	2
ets	2
her3	2
immune-evasion	2
inhibitor	2
journal-club	2
lung	2
measurement	2
mechanism	2
methods	2
mirna	2
notch	2
nsclc	2
pharmacogenetics	2
phosphatase	2
pi3k	2
progesterone-receptor	2
ptp1b	2
response	2
signalling	2
spheroid	2
target	2
treg	2
triple-negative	2
tyrosine	2
yb-1	2
basel	1
hr	1
justification	1
kim_	1
kinetic_modeling	1
moa	1
pathology	1
postmenopausal	1
prospective	1
slp2	1
th2	1
trial	1
wnt	1

Tag her2 [79 articles] Export

Related Tags